Long-term outcome for lymph node-positive prostate cancer

G. P. Swanson, M. W. Riggs, M. Herman

Research output: Contribution to journalArticlepeer-review


Although the number of men with lymph node-positive prostate cancer has declined, it is still significant and the challenge remains on how best to treat these patients. Only long-term follow-up can give a true indication of the outcome in prostate cancer. We evaluated our experience in treating lymph node-positive prostate cancer with a median follow-up of 10.2 years. The overall 5-year survival was 78% and the 10-year survival was 56%. Length of tumor control depends on the type of treatment given. Adding androgen ablation improves the duration of control dramatically, although optimal timing is still uncertain.

Original languageEnglish (US)
Pages (from-to)198-202
Number of pages5
JournalProstate Cancer and Prostatic Diseases
Issue number2
StatePublished - Jun 2008

ASJC Scopus subject areas

  • Oncology
  • Urology
  • Cancer Research


Dive into the research topics of 'Long-term outcome for lymph node-positive prostate cancer'. Together they form a unique fingerprint.

Cite this